SightfileU.S. market data from official filings

Companies › VRDN

VIRIDIAN THERAPEUTICS INC (VRDN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001590750 · EDGAR filings · Updated 2026-07-02

VIRIDIAN THERAPEUTICS INC (VRDN) has reported institutional ownership of 109.0%, with 226 institutional managers holding positions valued at $2.21B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
109.0%
Institutional managers
226
Reported 13F value
$2.21B
Insider activity
16 trans.
$9.93M net buying
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, VIRIDIAN THERAPEUTICS INC has 226 institutional holders and institutional ownership of 109.0%.

Insider activity

Insiders reported 16 transactions (1 buys, 1 sells) across 6 reporting insiders, with a net reported value of $9.93M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-05 (recurring since 2020-03-13) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2020-10-14 (recurring since 2020-10-14) — source filing. The authoritative details are those stated in the filing itself.

Related companies

SUMMIT THERAPEUTICS INC (SMMT) · GENMAB A/S (GMAB) · SAREPTA THERAPEUTICS INC (SRPT) · KODIAK SCIENCES (KOD) · ALUMIS INC (ALMS) · KINIKSA PHARMACEUTICALS INTL (KNSA)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.